Details of the Drug

General Information of Drug (ID: DMYQ0DV)

Drug Name
VLX1570
Synonyms SCKXBVLYWLLALY-ZSIIYVIPSA-N; VLX-1570; 1431280-51-1; BCP18900
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Phase 1 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C23H17F2N3O6
Canonical SMILES
C=CC(=O)N1CCC(=CC2=CC(=C(C=C2)F)[N+](=O)[O-])C(=O)C(=CC3=CC(=C(C=C3)F)[N+](=O)[O-])C1
InChI
InChI=1S/C23H17F2N3O6/c1-2-22(29)26-8-7-16(9-14-3-5-18(24)20(11-14)27(31)32)23(30)17(13-26)10-15-4-6-19(25)21(12-15)28(33)34/h2-6,9-12H,1,7-8,13H2/b16-9+,17-10+
InChIKey
SCKXBVLYWLLALY-CZCYGEDCSA-N
Cross-matching ID
PubChem CID
71523377
ChEBI ID
CHEMBL4441423
CAS Number
1956378-23-6
UNII
K6067N5M6N
DrugBank ID
DB16030
TTD ID
D0G7IF
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)